What We Do
APDN and The College of Nanoscale Science and Engineering (CNSE) of the University at Albany have formed a partnership to enable nanotechnology-driven innovations that would play a critical role in preventing the counterfeiting of computer chips.
The collaboration in the groundbreaking area of “nanosecurity” initially targets the $23 billion defense industry chip market and has the potential to impact a global $300 billion market in nanoelectronics.
Through joint research and development at CNSE’s Albany NanoTech Complex, CNSE and APDN intend to accelerate the development of APDN’s SigNature® DNA product – including the integration of new methods for DNA deposition on nanoelectronics wafers and computer chips both prior to, and including, final packaging – to ensure the integrity and security of processed wafers.
The partnership between CNSE and APDN will support research, development and deployment of authentication protocols and procedures in established process flows, including CMOS, MEMS, photonics, and other device derivatives, as well as advanced packaging technologies, such as 3-dimensional wafer-to-wafer and die-on-wafer. When realized, these advances would enable comprehensive supply chain protection well into the foreseeable future.
The collaboration comes on the heels of an amendment already passed by the Senate and House that would significantly strengthen protections against the wave of counterfeit electronic parts coming into the defense supply system. The new legislation is included in the 2012 National Defense Authorization Act and requires that military suppliers create and implement counterfeit detection and avoidance systems, among many other strict anti-counterfeiting provisions. These new requirements could be enabled through a CNSE-APDN partnership.
And while the spotlight is justifiably on protecting the defense supply chain, the private sector would also reap significant and immediate rewards from CNSE-APDN efforts.
Dr. James A. Hayward, President and CEO of Applied DNA Sciences, said, “With this partnership between the UAlbany NanoCollege and APDN, we create the field of ‘nanosecurity.’ Both entities contribute leading-edge technology and proven success in its commercialization. We are confident of results and in our capacity for near-term deployment.”
Dean Fuleihan, CNSE Executive Vice President for Strategic Partnerships, said, “The UAlbany NanoCollege is delighted to enter into this partnership with Applied DNA Sciences to enable innovative anti-counterfeiting technology that is vital to protecting American troops and U.S. military interests, both at home and abroad. This collaboration will accelerate research, development and commercialization to ensure the security and integrity of computer chips that drive our nation’s most advanced weaponry and intelligence systems, and further demonstrates the success of public-private partnerships in positioning CNSE and New York state as a hub for 21st century military technologies driven by nanotechnology know how.”
The UAlbany CNSE is the first college in the world dedicated to education, research, development and deployment in the emerging disciplines of nanoscience, nanoengineering, nanobioscience and nanoeconomics. With more than $14 billon in high-tech investments, CNSE represents the world’s most advanced university-driven research enterprise, offering students a one-of-a-kind academic experience and providing over 300 corporate partners with access to an unmatched ecosystem for leading-edge R&D and commercialization of nanoelectronics and nanotechnology innovations.
CNSE’s footprint spans upstate New York, including its Albany NanoTech Complex, an 800,000-square-foot megaplex with the only fully-integrated, 300mm wafer, computer chip pilot prototyping and demonstration line within 85,000 square feet of Class 1 capable cleanrooms. More than 2,600 scientists, researchers, engineers, students and faculty work here, from companies including IBM, Intel, GlobalFoundries, SEMATECH, Samsung, TSMC, Toshiba, Applied Materials, Tokyo Electron, ASML and Novellus Systems.
An expansion now underway, part of which will house the world’s first Global 450mm Consortium, will add nearly 500,000 square feet of next-generation infrastructure, an additional 50,000 square feet of Class 1 capable cleanrooms, and more than 1,000 scientists, researchers and engineers from CNSE and global corporations. In addition, CNSE’s Solar Energy Development Center in Halfmoon provides a prototyping and demonstration line for next-generation CIGS thin-film solar cells. CNSE’s Smart Systems Technology and Commercialization Center of Excellence (STC) in Rochester offers state-of-the-art capabilities for MEMS fabrication and packaging. CNSE also co-founded and manages operations at the Computer Chip Commercialization Center at SUNYIT in Utica and is a co-founder of the Nanotechnology Innovation and Commercialization Excelerator in Syracuse.
For information, visit http://www.sunycnse.com/Home.aspx
- our company
- investor information
- make an appointment
Binghamton University S3IP Center and Applied DNA Sciences Partner on DNA Authenticity Technologies for Microelectronics
Will research, commercialize applications for aerospace, defenseUALBANY NANOCOLLEGE & APPLIED DNA SCIENCES PARTNER ON NANOCHIP ANTI-COUNTERFEITING PROGRAM
Collaborative research will advance DNA deposition technologies targeting over $300B market for ‘nanosecurity’ applications in nanoelectronics, aerospace and defense